Eli Lilly has claimed FDA approval for its IL-23 inhibitor Omvoh as a treatment for moderately to severely active Crohn's disease, extending its use beyond ulcerative colitis (UC) for the first time.

Lilly’s emphasis on patient-reported outcomes (PROs) has differentiated Omvoh from its competitors, and the company will further its case at ECCO 2025 by unveiling results from the LUCENT-URGE ...

Novo Nordisk NVO and Eli Lilly LLY dominate the diabetes and obesity market on the back of the tremendous success of their ...

A high-level overview of Eli Lilly and Company (LLY) stock. View (LLY) real-time stock price, chart, news, analysis, analyst reviews and more.

Learn about the executive team and board of directors at Eli Lilly and Co (LLY:XNYS) and review their bios and compensation over the latest fiscal years.

Lilly presents first clinical data for its investigational, next-generation FRα targeting ADC in platinum-resistant ovarian cancer at the 2025 ASCO Annual Meeting PR Newswire Jun 2, 2025, 5:00:00 AM ...

Tea: To make blue lotus flower tea, add one premade tea bag or 3 to 5 grams of dried flowers to 1 to 2 cups (250 to 500 mL) of hot water. Let steep for 5 to 10 minutes. Smoking: If you choose to ...

Get the latest news and real-time alerts from Eli Lilly and Company (LLY) stock at Seeking Alpha.

Lilly Kersh is a general assignment reporter at The Dallas Morning News covering McKinney and Plano in Collin County. She graduated in 2024 from the ...